scholarly article | Q13442814 |
P50 | author | James P C Coverdale | Q87826887 |
Swati Arya | Q83576056 | ||
P2093 | author name string | Alan J Stewart | |
Claudia A Blindauer | |||
Siavash Khazaipoul | |||
P2860 | cites work | Zinc diet and Alzheimer's disease: a systematic review | Q22241775 |
A novel gene involved in zinc transport is deficient in the lethal milk mouse | Q24323282 | ||
Structure, properties, and engineering of the major zinc binding site on human albumin | Q24658366 | ||
Metals and Neuronal Metal Binding Proteins Implicated in Alzheimer's Disease | Q26765782 | ||
The Functions of Metallothionein and ZIP and ZnT Transporters: An Overview and Perspective | Q26766916 | ||
Blood-Borne Revitalization of the Aged Brain | Q26799718 | ||
Fishy business: effect of omega-3 fatty acids on zinc transporters and free zinc availability in human neuronal cells | Q26999257 | ||
Crystal structure of human ZAG, a fat-depleting factor related to MHC molecules | Q27617949 | ||
Crystallographic analysis reveals common modes of binding of medium and long-chain fatty acids to human serum albumin | Q27627815 | ||
Supramolecular Protein Engineering: DESIGN OF ZINC-STAPLED INSULIN HEXAMERS AS A LONG ACTING DEPOT | Q27660044 | ||
The metal face of protein tyrosine phosphatase 1B | Q28074241 | ||
Histidine-rich glycoprotein: A novel adaptor protein in plasma that modulates the immune, vascular and coagulation systems | Q28238035 | ||
Histidine-rich glycoprotein: the Swiss Army knife of mammalian plasma | Q28296528 | ||
Think zinc: New roles for zinc in the control of insulin secretion | Q28299051 | ||
Fatty acid binding to human serum albumin: new insights from crystallographic studies | Q28376781 | ||
Circulatory zinc transport is controlled by distinct interdomain sites on mammalian albumins | Q30252235 | ||
Zinc metalloproteins as medicinal targets. | Q30370883 | ||
Counting the zinc-proteins encoded in the human genome | Q33231024 | ||
Fatty acids, lipotoxicity and insulin secretion | Q33537945 | ||
Imaging mobile zinc in biology | Q33762045 | ||
Potential interactions of zinc in the neuroendocrine-endocrine disturbances of diabetes mellitus type 2. | Q33801097 | ||
Perinatal omega-3 polyunsaturated fatty acid supply modifies brain zinc homeostasis during adulthood | Q33821703 | ||
The Emerging Role for Zinc in Depression and Psychosis | Q33857369 | ||
Neurobiology of zinc-influenced eating behavior | Q33901147 | ||
Zinc homeostasis in humans | Q33912992 | ||
Free zinc ions outside a narrow concentration range are toxic to a variety of cells in vitro | Q33960988 | ||
Investigating the role of transferrin in the distribution of iron, manganese, copper, and zinc | Q33992191 | ||
Mammalian zinc transport, trafficking, and signals | Q33997055 | ||
The efficacy of zinc supplementation in depression: systematic review of randomised controlled trials | Q34204382 | ||
Allosteric inhibition of cobalt binding to albumin by fatty acids: implications for the detection of myocardial ischemia | Q42718711 | ||
Diagnostic value of ischemia-modified albumin in patients with suspected acute coronary syndrome | Q43160493 | ||
Zinc enhances adiponectin oligomerization to octadecamers but decreases the rate of disulfide bond formation | Q43590642 | ||
Evaluation of human serum albumin cobalt binding assay for the assessment of myocardial ischemia and myocardial infarction | Q44372124 | ||
Zinc(II) and copper(II) binding to serum albumin. A comparative study of dog, bovine, and human albumin. | Q44520206 | ||
Free fatty acids during acute myocardial infarction | Q44629473 | ||
Contribution of elevated free fatty acid levels to the lack of glucose effectiveness in type 2 diabetes | Q44631815 | ||
Higher fasting plasma free fatty acid levels are associated with lower insulin secretion in children and adults and a higher incidence of type 2 diabetes | Q44759598 | ||
Crystallographic studies of ligand binding by Zn-alpha2-glycoprotein | Q45101019 | ||
Effect of changes in plasma levels of free fatty acids on plasma glucagon, insulin, and growth hormone in man. | Q45207410 | ||
Serum zinc level and coronary heart disease events in patients with type 2 diabetes | Q45231492 | ||
Hemostasis, endothelial stress, inflammation, and the metabolic syndrome | Q46247156 | ||
Oxidative stress and the amyloid beta peptide in Alzheimer's disease | Q46272723 | ||
Zinc status is associated with inflammation, oxidative stress, lipid, and glucose metabolism | Q46297850 | ||
Zn2+ chelation by serum albumin improves hexameric Zn2+-insulin dissociation into monomers after exocytosis | Q46682227 | ||
Fatty acids influence binding of cobalt to serum albumin in patients with fatty liver | Q46697042 | ||
Strong and weak zinc binding sites in human zinc-α2-glycoprotein. | Q46907456 | ||
Concentrations of extracellular free zinc (pZn)e in the central nervous system during simple anesthetization, ischemia and reperfusion | Q46916576 | ||
The cobalt-albumin binding assay: insights into its mode of action | Q46928440 | ||
Intrinsic stoichiometric equilibrium constants for the binding of zinc(II) and copper(II) to the high affinity site of serum albumin. | Q46982142 | ||
Zinc as a Gatekeeper of Immune Function. | Q47256027 | ||
Serum zinc levels in acute psychiatric patients: A case series | Q47655203 | ||
Spectroscopic and thermodynamic determination of three distinct binding sites for Co(II) ions in human serum albumin | Q47678446 | ||
Molecular Insights into Human Serum Albumin as a Receptor of Amyloid-β in the Extracellular Region. | Q47773081 | ||
Neurotoxicity of Zinc. | Q47827289 | ||
Iron, Copper, and Zinc Concentration in Aβ Plaques in the APP/PS1 Mouse Model of Alzheimer's Disease Correlates with Metal Levels in the Surrounding Neuropil. | Q47853972 | ||
Multi-metal binding site of serum albumin | Q47856742 | ||
Zinc Deficiency Is associated With Depressive Symptoms-Results From the Berlin Aging Study II. | Q47897076 | ||
Associations between dietary intakes of iron, copper and zinc with risk of type 2 diabetes mellitus: A large population-based prospective cohort study | Q47958613 | ||
Atomic-resolution map of the interactions between an amyloid inhibitor protein and amyloid β (Aβ) peptides in the monomer and protofibril states. | Q47966515 | ||
Effect of glycation on human serum albumin-zinc interaction: a biophysical study | Q88271169 | ||
Omega-6 polyunsaturated fatty acids, serum zinc, delta-5- and delta-6-desaturase activities and incident metabolic syndrome | Q88499575 | ||
Is zinc an intra-islet regulator of glucagon secretion? | Q90856492 | ||
Zinc supplementation in prediabetes: A randomized double-blind placebo-controlled clinical trial | Q48123991 | ||
The Zinc Sensing Receptor, ZnR/GPR39, in Health and Disease. | Q48124115 | ||
Zinc Status and Autoimmunity: A Systematic Review and Meta-Analysis. | Q48260434 | ||
The Impact of Synaptic Zn2+ Dynamics on Cognition and Its Decline. | Q48307478 | ||
Characterization of the role of metallothionein-3 in an animal model of Alzheimer's disease | Q48464419 | ||
Location of high and low affinity fatty acid binding sites on human serum albumin revealed by NMR drug-competition analysis | Q48682040 | ||
Zinc dynamics and action at excitatory synapses | Q48726808 | ||
Zinc in Cellular Regulation: The Nature and Significance of "Zinc Signals". | Q49217377 | ||
High Free Fatty Acid Levels Are Associated with Stroke Recurrence and Poor Functional Outcome in Chinese Patients with Ischemic Stroke | Q49498695 | ||
Neuroscience: The power of plasma | Q49720566 | ||
Zinc regulates vascular endothelial activities through zinc-sensing receptor ZnR/GPR39. | Q49918191 | ||
Leptin and the maintenance of elevated body weight | Q50100748 | ||
Role of Zinc Homeostasis in the Pathogenesis of Diabetes and Obesity | Q50131986 | ||
Serum Albumin's Protective Inhibition of Amyloid-β Fibre Formation Is Suppressed by Cholesterol, Fatty Acids and Warfarin | Q50153845 | ||
Modulation of linoleic acid-binding properties of human serum albumin by divalent metal cations. | Q50955973 | ||
Leptin, NPY, Melatonin and Zinc Levels in Experimental Hypothyroidism and Hyperthyroidism: The Relation to Zinc. | Q51185103 | ||
Metals and Alzheimer's Disease: How Far Have We Come in the Clinic? | Q51760893 | ||
Plasma fatty acid levels may regulate the Zn(2+)-dependent activities of histidine-rich glycoprotein. | Q51777768 | ||
Ischemia-modified albumin: is it a reliable diagnostic and prognostic marker for myocardial ischemia in real clinical practice? | Q51814034 | ||
Abnormal Myocardial Dietary Fatty Acid Metabolism and Diabetic Cardiomyopathy. | Q52329053 | ||
Association of Serum Zinc Level With Prognosis in Patients With Heart Failure. | Q52675673 | ||
Competition for zinc among serum albumin and amino acids. | Q52976501 | ||
Control of free fatty acids during acute myocardial ischaemia. | Q53804460 | ||
Zinc ions modulate protein tyrosine phosphatase 1B activity. | Q54355379 | ||
Interactions of very long-chain saturated fatty acids with serum albumin | Q56528744 | ||
Ischemia-modified albumin: Crosstalk between fatty acid and cobalt binding | Q58805331 | ||
Disturbed zinc homeostasis in diabetic patients by in vitro and in vivo analysis of insulinomimetic activity of zinc | Q60691146 | ||
The relative affinity of transferrin and albumin for zinc | Q66979194 | ||
Serum magnesium, copper, and zinc concentrations in acute myocardial infarction | Q67558959 | ||
Binding of cadmium(II) and zinc(II) to human and dog serum albumins. An equilibrium dialysis and 113Cd-NMR study | Q67891944 | ||
Serum zinc concentration in acute myocardial infaction | Q68864567 | ||
Carbon 13 NMR studies of saturated fatty acids bound to bovine serum albumin. I. The filling of individual fatty acid binding sites | Q69139623 | ||
Identification and determination of copper--and zinc--protein complexes in blood plasma after chromatographic separation on DEAE-Sepharose CL-6B | Q70636921 | ||
Distribution of zinc amongst human serum proteins determined by affinity chromatography and atomic-absorption spectrophotometry | Q71784114 | ||
Longitudinal changes in serum zinc concentration and distribution after acute myocardial infarction | Q72455799 | ||
A novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia-a preliminary report | Q73179417 | ||
Human fetal endothelial cells acquire zinc(II) from both the protein bound and nonprotein bound pools in serum | Q73446745 | ||
Amyloid-beta peptides interact with plasma proteins and erythrocytes: implications for their quantitation in plasma | Q73458813 | ||
Zinc may be a mediator of leptin production in humans | Q73840298 | ||
Albumin facilitates zinc acquisition by endothelial cells | Q73920269 | ||
1H and (113)Cd NMR Investigations of Cd(2+) and Zn(2+) Binding Sites on Serum Albumin: Competition with Ca(2+), Ni(2+), Cu(2+), and Zn(2+) | Q74821605 | ||
The interaction between human and bovine serum albumin and zinc studied by a competitive spectrophotometry | Q78209796 | ||
Effects of zinc deficiency and supplementation on plasma leptin levels in rats | Q81685522 | ||
Serum zinc and copper status in dyslipidaemic patients with and without established coronary artery disease | Q83037155 | ||
Zinc-induced oligomerization of zinc α2 glycoprotein reveals multiple fatty acid-binding sites | Q86527964 | ||
Zinc promotes clot stability by accelerating clot formation and modifying fibrin structure | Q86532282 | ||
Zinc delays clot lysis by attenuating plasminogen activation and plasmin-mediated fibrin degradation | Q86957775 | ||
Locating high-affinity fatty acid-binding sites on albumin by x-ray crystallography and NMR spectroscopy | Q34212667 | ||
Zinc and regulation of inflammatory cytokines: implications for cardiometabolic disease | Q34291746 | ||
Potential roles of zinc in the pathophysiology and treatment of major depressive disorder | Q34337912 | ||
Zinc in depression: a meta-analysis. | Q34353975 | ||
Zinc-ligand interactions modulate assembly and stability of the insulin hexamer -- a review | Q34450433 | ||
Advances in the molecular understanding of biological zinc transport | Q34459994 | ||
Dietary zinc supplementation of 3xTg-AD mice increases BDNF levels and prevents cognitive deficits as well as mitochondrial dysfunction | Q34561777 | ||
Interdomain zinc site on human albumin | Q34915559 | ||
Plasma free fatty acid levels influence Zn(2+) -dependent histidine-rich glycoprotein-heparin interactions via an allosteric switch on serum albumin | Q35023180 | ||
Zinc homeostasis-regulating proteins: new drug targets for triggering cell fate. | Q35109041 | ||
Obesity, insulin resistance and free fatty acids | Q35204838 | ||
Brain-Delivery of Zinc-Ions as Potential Treatment for Neurological Diseases: Mini Review. | Q35561700 | ||
The neurophysiology and pathology of brain zinc | Q35572191 | ||
A dominant negative heterozygous G87R mutation in the zinc transporter, ZnT-2 (SLC30A2), results in transient neonatal zinc deficiency | Q36215910 | ||
Synaptic release of zinc from brain slices: factors governing release, imaging, and accurate calculation of concentration | Q36388087 | ||
Carbon 13 NMR studies of saturated fatty acids bound to bovine serum albumin. II. Electrostatic interactions in individual fatty acid binding sites. | Q36468667 | ||
Fatty acid synthase and cancer: new application of an old pathway | Q36508237 | ||
Effect of maximal exercise on the short-term kinetics of zinc metabolism in sedentary men. | Q36767829 | ||
Fatty acid-specific fluorescent probes and their use in resolving mixtures of unbound free fatty acids in equilibrium with albumin | Q36844298 | ||
Zinc alpha 2-glycoprotein: a multidisciplinary protein. | Q37196053 | ||
Application of fluoroimmunoassay to cerebrospinal fluid immunoglobulin G and albumin | Q37317794 | ||
Albumin as a zinc carrier: properties of its high-affinity zinc-binding site. | Q37330432 | ||
The biological inorganic chemistry of zinc ions. | Q37433265 | ||
Zinc and the aging brain | Q37496663 | ||
Zn(2+)-transporter-8: a dual role in diabetes | Q37572642 | ||
Efficacy and Safety of Plasma Exchange with 5% Albumin to Modify Cerebrospinal Fluid and Plasma Amyloid-β Concentrations and Cognition Outcomes in Alzheimer's Disease Patients: A Multicenter, Randomized, Controlled Clinical Trial | Q37589619 | ||
Lessons from the crystallographic analysis of small molecule binding to human serum albumin | Q37595256 | ||
Zinc in the physiology and pathology of the CNS. | Q37614216 | ||
Allostery in a monomeric protein: the case of human serum albumin. | Q37719888 | ||
Zinc and redox signaling: perturbations associated with cardiovascular disease and diabetes mellitus | Q37766871 | ||
Zinc and cardiovascular disease. | Q37800535 | ||
Zinc homeostasis and signaling in health and diseases: Zinc signaling | Q37887564 | ||
Regulation of glucagon secretion by zinc: lessons from the β cell-specific Znt8 knockout mouse model. | Q37913522 | ||
Human serum albumin: from bench to bedside | Q37974420 | ||
Insulino-mimetic and anti-diabetic effects of zinc | Q38069792 | ||
Fatty acid binding to serum albumin: molecular simulation approaches. | Q38097307 | ||
Fatty acid binding to plasma albumin | Q38103323 | ||
Allosteric modulation of zinc speciation by fatty acids | Q38111113 | ||
Binding of transition metal ions to albumin: sites, affinities and rates | Q38118028 | ||
NMR reveals molecular interactions and dynamics of fatty acid binding to albumin | Q38128499 | ||
Zinc and insulin in pancreatic beta-cells | Q38131728 | ||
Multiple impacts of zinc on immune function | Q38188444 | ||
The role of intracellular zinc release in aging, oxidative stress, and Alzheimer's disease | Q38214602 | ||
Glia and zinc in ageing and Alzheimer's disease: a mechanism for cognitive decline? | Q38227862 | ||
The zinc paradigm for metalloneurochemistry | Q38288186 | ||
Zinc in Alzheimer's Disease: A Meta-Analysis of Serum, Plasma, and Cerebrospinal Fluid Studies | Q38362089 | ||
Traumatic Brain Injury, Chronic Traumatic Encephalopathy, and Alzheimer's Disease: Common Pathologies Potentiated by Altered Zinc Homeostasis | Q38380370 | ||
Significance of the degree of synaptic Zn²⁺ signaling in cognition | Q38679721 | ||
Fatty Acid-Mediated Inhibition of Metal Binding to the Multi-Metal Site on Serum Albumin: Implications for Cardiovascular Disease. | Q38735509 | ||
Disruption of brain zinc homeostasis promotes the pathophysiological progress of Alzheimer's disease | Q38736443 | ||
Immunological orchestration of zinc homeostasis: The battle between host mechanisms and pathogen defenses | Q38752621 | ||
Plasma/Serum Zinc Status During Aerobic Exercise Recovery: A Systematic Review and Meta-Analysis | Q38853653 | ||
Techniques for measuring cellular zinc | Q38942642 | ||
The biochemical effects of extracellular Zn(2+) and other metal ions are severely affected by their speciation in cell culture media. | Q38943563 | ||
Decreased adipose tissue zinc content is associated with metabolic parameters in high fat fed Wistar rats | Q39029854 | ||
Fish consumption and omega-3 fatty acid supplementation for prevention or treatment of cognitive decline, dementia or Alzheimer's disease in older adults - any news? | Q39039118 | ||
Zinc's role in the glycemic control of patients with type 2 diabetes: a systematic review | Q39110769 | ||
Zinc in Pancreatic Islet Biology, Insulin Sensitivity, and Diabetes | Q39236533 | ||
Zinc transporter 3 (ZnT3) and vesicular zinc in central nervous system function | Q39380047 | ||
Role of zinc in lipid and fatty acid metabolism and in membranes. | Q39546892 | ||
The Rapid Exchange of Zinc(2+) Enables Trace Levels to Profoundly Influence Amyloid-β Misfolding and Dominates Assembly Outcomes in Cu(2+)/Zn(2+) Mixtures | Q39672070 | ||
Zinc alpha2 glycoprotein alleviates palmitic acid-induced intracellular lipid accumulation in hepatocytes | Q39708663 | ||
The omega-3 fatty acid, DHA, decreases neuronal cell death in association with altered zinc transport. | Q39763980 | ||
Drug binding in plasma. A summary of recent trends in the study of drug and hormone binding | Q40730351 | ||
Zinc and manganese contents of micro-dissected pancreatic islets of some rodents. A microchemical study in adult and newborn guinea pigs, rats, Chinese hamsters and spiny mice | Q40824779 | ||
Role of free fatty acids in endothelial dysfunction | Q41147225 | ||
A molecular mechanism for modulating plasma Zn speciation by fatty acids | Q41470913 | ||
Human serum albumin can regulate amyloid-β peptide fiber growth in the brain interstitium: implications for Alzheimer disease | Q42322241 | ||
Zn2+ mediates high affinity binding of heparin to the αC domain of fibrinogen | Q42666355 | ||
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 532-542 | |
P577 | publication date | 2018-09-25 | |
P1433 | published in | BBA - Molecular and Cell Biology of Lipids | Q15752265 |
P1476 | title | Crosstalk between zinc and free fatty acids in plasma | |
P478 | volume | 1864 |
Q92988352 | Changes in Plasma Free Fatty Acids Associated with Type-2 Diabetes |
Q92328545 | Coagulatory Defects in Type-1 and Type-2 Diabetes |
Q91130161 | Method and its Composition for encapsulation, stabilization, and delivery of siRNA in Anionic polymeric nanoplex: An In vitro- In vivo Assessment |
Search more.